                         SEQUENCE LISTING

<110>  JANSSEN BIOTECH, INC.
 
<120>  MATERIALS AND METHODS FOR TARGETING T REGULATORY CELLS FOR 
       ENHANCING IMMUNE SURVEILLANCE

<130>  14620-627-228

<140>
<141>

<150>  US 63/151,636
<151>  2021-02-19

<150>  US 63/151,635
<151>  2021-02-19

<150>  US 63/151,634
<151>  2021-02-19

<150>  US 63/151,633
<151>  2021-02-19

<150>  US 63/151,631
<151>  2021-02-19

<160>  14    

<170>  PatentIn version 3.5

<210>  1
<211>  115
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-CD25 VH

<400>  1

Gln Leu Gln Gln Ser Gly Thr Val Leu Ala Arg Pro Gly Ala Ser Val 
1               5                   10                  15      


Lys Met Ser Cys Lys Ala Ser Gly Tyr Ser Phe Thr Arg Tyr Trp Met 
            20                  25                  30          


His Trp Ile Lys Gln Arg Pro Gly Gln Gly Leu Glu Trp Ile Gly Ala 
        35                  40                  45              


Ile Tyr Pro Gly Asn Ser Asp Thr Ser Tyr Asn Gln Lys Phe Glu Gly 
    50                  55                  60                  


Lys Ala Lys Leu Thr Ala Val Thr Ser Ala Ser Thr Ala Tyr Met Glu 
65                  70                  75                  80  


Leu Ser Ser Leu Thr His Glu Asp Ser Ala Val Tyr Tyr Cys Ser Arg 
                85                  90                  95      


Asp Tyr Gly Tyr Tyr Phe Asp Phe Trp Gly Gln Gly Thr Thr Leu Thr 
            100                 105                 110         


Val Ser Ser 
        115 


<210>  2
<211>  104
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-CD25 VL

<400>  2

Gln Ile Val Ser Thr Gln Ser Pro Ala Ile Met Ser Ala Ser Pro Gly 
1               5                   10                  15      


Glu Lys Val Thr Met Thr Cys Ser Ala Ser Ser Ser Arg Ser Tyr Met 
            20                  25                  30          


Gln Trp Tyr Gln Gln Lys Pro Gly Thr Ser Pro Lys Arg Trp Ile Tyr 
        35                  40                  45              


Asp Thr Ser Lys Leu Ala Ser Gly Val Pro Ala Arg Phe Ser Gly Ser 
    50                  55                  60                  


Gly Ser Gly Thr Ser Tyr Ser Leu Thr Ile Ser Ser Met Glu Ala Glu 
65                  70                  75                  80  


Asp Ala Ala Thr Tyr Tyr Cys His Gln Arg Ser Ser Tyr Thr Phe Gly 
                85                  90                  95      


Gly Gly Thr Lys Leu Glu Ile Lys 
            100                 


<210>  3
<211>  116
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-CD39 VH

<400>  3

Glu Val Gln Leu Gln Gln Ser Gly Pro Glu Leu Val Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Met Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asp Tyr 
            20                  25                  30          


Asn Met His Trp Val Lys Gln Ser His Gly Arg Thr Leu Glu Trp Ile 
        35                  40                  45              


Gly Tyr Ile Val Pro Leu Asn Gly Gly Ser Thr Phe Asn Gln Lys Phe 
    50                  55                  60                  


Lys Gly Arg Ala Thr Leu Thr Val Asn Thr Ser Ser Arg Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Arg Ser Leu Thr Ser Glu Asp Ser Ala Ala Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Gly Thr Arg Phe Ala Tyr Trp Gly Gln Gly Thr Leu Val 
            100                 105                 110         


Thr Val Ser Ala 
        115     


<210>  4
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-CD39 VL

<400>  4

Asp Ile Val Leu Thr Gln Ser Pro Ala Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Gln Arg Ala Thr Ile Ser Cys Arg Ala Ser Glu Ser Val Asp Asn Phe 
            20                  25                  30          


Gly Val Ser Phe Met Tyr Trp Phe Gln Gln Lys Pro Gly Gln Pro Pro 
        35                  40                  45              


Asn Leu Leu Ile Tyr Gly Ala Ser Asn Gln Gly Ser Gly Val Pro Ala 
    50                  55                  60                  


Arg Phe Arg Gly Ser Gly Ser Gly Thr Asp Phe Ser Leu Asn Ile His 
65                  70                  75                  80  


Pro Met Glu Ala Asp Asp Thr Ala Met Tyr Phe Cys Gln Gln Thr Lys 
                85                  90                  95      


Glu Val Pro Tyr Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110     


<210>  5
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-RSV VH

<400>  5

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Tyr Asp Gly Ile Tyr Gly Glu Leu Asp Phe Trp Gly Cys Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  6
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-RSV VL

<400>  6

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Cys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  7
<211>  490
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-CD25 (Basiliximab)

<400>  7

Met Ala Trp Val Trp Thr Leu Leu Phe Leu Met Ala Ala Ala Gln Ser 
1               5                   10                  15      


Ile Gln Ala Gln Ile Val Ser Thr Gln Ser Pro Ala Ile Met Ser Ala 
            20                  25                  30          


Ser Pro Gly Glu Lys Val Thr Met Thr Cys Ser Ala Ser Ser Ser Arg 
        35                  40                  45              


Ser Tyr Met Gln Trp Tyr Gln Gln Lys Pro Gly Thr Ser Pro Lys Arg 
    50                  55                  60                  


Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser Gly Val Pro Ala Arg Phe 
65                  70                  75                  80  


Ser Gly Ser Gly Ser Gly Thr Ser Tyr Ser Leu Thr Ile Ser Ser Met 
                85                  90                  95      


Glu Ala Glu Asp Ala Ala Thr Tyr Tyr Cys His Gln Arg Ser Ser Tyr 
            100                 105                 110         


Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys Gly Gly Ser Glu Gly 
        115                 120                 125             


Lys Ser Ser Gly Ser Gly Ser Glu Ser Lys Ser Thr Gly Gly Ser Gln 
    130                 135                 140                 


Leu Gln Gln Ser Gly Thr Val Leu Ala Arg Pro Gly Ala Ser Val Lys 
145                 150                 155                 160 


Met Ser Cys Lys Ala Ser Gly Tyr Ser Phe Thr Arg Tyr Trp Met His 
                165                 170                 175     


Trp Ile Lys Gln Arg Pro Gly Gln Gly Leu Glu Trp Ile Gly Ala Ile 
            180                 185                 190         


Tyr Pro Gly Asn Ser Asp Thr Ser Tyr Asn Gln Lys Phe Glu Gly Lys 
        195                 200                 205             


Ala Lys Leu Thr Ala Val Thr Ser Ala Ser Thr Ala Tyr Met Glu Leu 
    210                 215                 220                 


Ser Ser Leu Thr His Glu Asp Ser Ala Val Tyr Tyr Cys Ser Arg Asp 
225                 230                 235                 240 


Tyr Gly Tyr Tyr Phe Asp Phe Trp Gly Gln Gly Thr Thr Leu Thr Val 
                245                 250                 255     


Ser Ser Glu Pro Lys Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys 
            260                 265                 270         


Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser Val Phe Leu Phe Pro Pro 
        275                 280                 285             


Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys 
    290                 295                 300                 


Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp 
305                 310                 315                 320 


Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu 
                325                 330                 335     


Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu 
            340                 345                 350         


His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn 
        355                 360                 365             


Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly 
    370                 375                 380                 


Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu 
385                 390                 395                 400 


Met Thr Lys Asn Gln Val Ser Leu Trp Cys Leu Val Lys Gly Phe Tyr 
                405                 410                 415     


Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn 
            420                 425                 430         


Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe 
        435                 440                 445             


Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn 
    450                 455                 460                 


Val Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr 
465                 470                 475                 480 


Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys 
                485                 490 


<210>  8
<211>  465
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-CD39 HC

<400>  8

Met Ala Trp Val Trp Thr Leu Leu Phe Leu Met Ala Ala Ala Gln Ser 
1               5                   10                  15      


Ile Gln Ala Glu Val Gln Leu Gln Gln Ser Gly Pro Glu Leu Val Lys 
            20                  25                  30          


Pro Gly Ala Ser Val Lys Met Ser Cys Lys Ala Ser Gly Tyr Thr Phe 
        35                  40                  45              


Thr Asp Tyr Asn Met His Trp Val Lys Gln Ser His Gly Arg Thr Leu 
    50                  55                  60                  


Glu Trp Ile Gly Tyr Ile Val Pro Leu Asn Gly Gly Ser Thr Phe Asn 
65                  70                  75                  80  


Gln Lys Phe Lys Gly Arg Ala Thr Leu Thr Val Asn Thr Ser Ser Arg 
                85                  90                  95      


Thr Ala Tyr Met Glu Leu Arg Ser Leu Thr Ser Glu Asp Ser Ala Ala 
            100                 105                 110         


Tyr Tyr Cys Ala Arg Gly Gly Thr Arg Phe Ala Tyr Trp Gly Gln Gly 
        115                 120                 125             


Thr Leu Val Thr Val Ser Ala Ala Ser Thr Lys Gly Pro Ser Val Phe 
    130                 135                 140                 


Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu 
145                 150                 155                 160 


Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp 
                165                 170                 175     


Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu 
            180                 185                 190         


Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser 
        195                 200                 205             


Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro 
    210                 215                 220                 


Ser Asn Thr Lys Val Asp Lys Lys Val Glu Pro Lys Ser Cys Asp Lys 
225                 230                 235                 240 


Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro 
                245                 250                 255     


Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser 
            260                 265                 270         


Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp 
        275                 280                 285             


Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn 
    290                 295                 300                 


Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val 
305                 310                 315                 320 


Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu 
                325                 330                 335     


Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys 
            340                 345                 350         


Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr 
        355                 360                 365             


Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Ser 
    370                 375                 380                 


Cys Ala Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu 
385                 390                 395                 400 


Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu 
                405                 410                 415     


Asp Ser Asp Gly Ser Phe Phe Leu Val Ser Lys Leu Thr Val Asp Lys 
            420                 425                 430         


Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu 
        435                 440                 445             


Ala Leu His Asn Arg Phe Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly 
    450                 455                 460                 


Lys 
465 


<210>  9
<211>  237
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-CD39 LC

<400>  9

Met Ala Trp Val Trp Thr Leu Leu Phe Leu Met Ala Ala Ala Gln Ser 
1               5                   10                  15      


Ile Gln Ala Asp Ile Val Leu Thr Gln Ser Pro Ala Ser Leu Ala Val 
            20                  25                  30          


Ser Leu Gly Gln Arg Ala Thr Ile Ser Cys Arg Ala Ser Glu Ser Val 
        35                  40                  45              


Asp Asn Phe Gly Val Ser Phe Met Tyr Trp Phe Gln Gln Lys Pro Gly 
    50                  55                  60                  


Gln Pro Pro Asn Leu Leu Ile Tyr Gly Ala Ser Asn Gln Gly Ser Gly 
65                  70                  75                  80  


Val Pro Ala Arg Phe Arg Gly Ser Gly Ser Gly Thr Asp Phe Ser Leu 
                85                  90                  95      


Asn Ile His Pro Met Glu Ala Asp Asp Thr Ala Met Tyr Phe Cys Gln 
            100                 105                 110         


Gln Thr Lys Glu Val Pro Tyr Thr Phe Gly Gly Gly Thr Lys Leu Glu 
        115                 120                 125             


Ile Lys Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser 
    130                 135                 140                 


Asp Glu Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn 
145                 150                 155                 160 


Asn Phe Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala 
                165                 170                 175     


Leu Gln Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys 
            180                 185                 190         


Asp Ser Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp 
        195                 200                 205             


Tyr Glu Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu 
    210                 215                 220                 


Ser Ser Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys 
225                 230                 235         


<210>  10
<211>  495
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-RSV (clone B21M)

<400>  10

Met Ala Trp Val Trp Thr Leu Leu Phe Leu Met Ala Ala Ala Gln Ser 
1               5                   10                  15      


Ile Gln Ala Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala 
            20                  25                  30          


Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile 
        35                  40                  45              


Ser Ser Tyr Leu Asn Trp Tyr Gln Gln Lys Pro Gly Cys Ala Pro Lys 
    50                  55                  60                  


Leu Leu Ile Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg 
65                  70                  75                  80  


Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser 
                85                  90                  95      


Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser 
            100                 105                 110         


Thr Pro Leu Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Gly Gly 
        115                 120                 125             


Gly Ser Gly Gly Ser Gly Gly Cys Pro Pro Cys Gly Gly Ser Gly Gly 
    130                 135                 140                 


Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
145                 150                 155                 160 


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
                165                 170                 175     


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
            180                 185                 190         


Ser Ala Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
        195                 200                 205             


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
    210                 215                 220                 


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
225                 230                 235                 240 


Ala Lys Tyr Asp Gly Ile Tyr Gly Glu Leu Asp Phe Trp Gly Cys Gly 
                245                 250                 255     


Thr Leu Val Thr Val Ser Ser Glu Pro Lys Ser Cys Asp Lys Thr His 
            260                 265                 270         


Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser Val 
        275                 280                 285             


Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr 
    290                 295                 300                 


Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro Glu 
305                 310                 315                 320 


Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys 
                325                 330                 335     


Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser 
            340                 345                 350         


Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys 
        355                 360                 365             


Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile 
    370                 375                 380                 


Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro 
385                 390                 395                 400 


Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Trp Cys Leu 
                405                 410                 415     


Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn 
            420                 425                 430         


Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser 
        435                 440                 445             


Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg 
    450                 455                 460                 


Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu 
465                 470                 475                 480 


His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys 
                485                 490                 495 


<210>  11
<211>  1485
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Anti-CD25 (Basiliximab)

<400>  11
gccgccacca tggcctgggt gtggaccctg ctgttcctga tggccgccgc ccagagcatc       60

caggcccaaa ttgtgtctac ccagtctcct gccatcatgt ccgcctctcc aggcgagaaa      120

gtgacaatga cctgctccgc ctcctcctct cggtcctaca tgcagtggta tcagcagaag      180

cccggcacct ctcctaagcg gtggatctac gatacctcca agctggcttc tggcgtgcca      240

gccagatttt ctggctctgg ctccggcacc agctactccc tgaccatctc ttctatggaa      300

gccgaggacg ccgccaccta ctactgtcac cagagatcct cttacacctt cggcggaggc      360

accaagctgg aaatcaaagg cggctctgag ggcaagtcct ccggctctgg atctgagtct      420

aagtctaccg gcggatccca gctgcagcag tctggaacag ttttggccag acctggcgcc      480

tccgtgaaga tgtcttgcaa ggcctctggc tacagcttca cccggtactg gatgcactgg      540

atcaagcaga ggcctggaca gggactcgag tggatcggag ctatctaccc tggcaactcc      600

gacacctcct acaaccagaa gttcgagggc aaagccaagc tgaccgccgt gacctctgct      660

tccacagcct atatggaact gtcctctctg acccacgagg actccgccgt gtactactgc      720

tctagagact acggctacta cttcgacttc tggggccagg gcacaaccct gacagtttct      780

tctgagccca aatcttgtga caaaactcac acatgtccac cgtgcccagc acctgaactc      840

ctggggggac cgtcagtctt cctcttcccc ccaaaaccca aggacaccct catgatctcc      900

cggacccctg aggtcacatg cgtggtggtg gacgtgagcc acgaagaccc tgaggtcaag      960

ttcaactggt acgtggacgg cgtggaggtg cataatgcca agacaaagcc gcgggaggag     1020

cagtacaaca gcacgtaccg tgtggtcagc gtcctcaccg tcctgcacca ggactggctg     1080

aatggcaagg agtacaagtg caaggtctcc aacaaagccc tcccagcccc catcgagaaa     1140

accatctcca aagccaaagg gcagccccga gaaccacagg tgtacaccct gcccccatcc     1200

cgggaggaga tgaccaagaa ccaggtcagc ctgtggtgcc tggtcaaagg cttctatccc     1260

agcgacatcg ccgtggagtg ggagagcaat gggcagccgg agaacaacta caagaccacg     1320

cctcccgtgc tggactccga cggctccttc ttcctctaca gcaagctcac cgtggacaag     1380

tctagatggc agcaggggaa cgtcttctca tgctccgtga tgcatgaggc tctgcacaac     1440

cactacacgc agaagagcct ctccctgtct ccgggtaaat gatag                     1485


<210>  12
<211>  1410
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Anti-CD39 HC

<400>  12
gccgccacca tggcctgggt gtggaccctg ctgttcctga tggccgccgc ccagagcatc       60

caggccgaag ttcaattgca gcagtctggc cctgagctgg tcaaacctgg cgcctctgtg      120

aagatgtctt gcaaggcctc tggctacacc ttcaccgact acaacatgca ctgggtcaag      180

cagtcccacg gcagaacact ggaatggatc ggctacatcg tgcctctgaa cggcggctcc      240

accttcaacc agaagttcaa gggcagagct accctgaccg tgaacacctc ctctcggacc      300

gcctacatgg aactgagatc cctgacctct gaggactccg ccgcctacta ttgtgctaga      360

ggcggcacca gatttgccta ttggggacag ggaaccctgg tcaccgtttc tgctgcctcc      420

accaagggcc catcggtctt ccccctggca ccctcctcca agagcacctc tgggggcaca      480

gcggccctgg gctgcctggt caaggactac ttccccgaac cggtgacggt gtcgtggaac      540

tcaggcgccc tgaccagcgg cgtgcacacc ttcccggctg tcctacagtc ctcaggactc      600

tactccctca gcagcgtggt gaccgtgccc tccagcagct tgggcaccca gacctacatc      660

tgcaacgtga atcacaagcc cagcaacacc aaggtggaca agaaagttga gcccaaatct      720

tgtgacaaaa ctcacacatg tccaccgtgc ccagcacctg aactcctggg gggaccgtca      780

gtcttcctct tccccccaaa acccaaggac accctcatga tctcccggac ccctgaggtc      840

acatgcgtgg tggtggacgt gagccacgaa gaccctgagg tcaagttcaa ctggtacgtg      900

gacggcgtgg aggtgcataa tgccaagaca aagccgcggg aggagcagta caacagcacg      960

taccgtgtgg tcagcgtcct caccgtcctg caccaggact ggctgaatgg caaggagtac     1020

aagtgcaagg tctccaacaa agccctccca gcccccatcg agaaaaccat ctccaaagcc     1080

aaagggcagc cccgagaacc acaggtgtac accctgcccc catcccggga ggagatgacc     1140

aagaaccagg tcagcctgtc ctgcgccgtc aaaggcttct atcccagcga catcgccgtg     1200

gagtgggaga gcaatgggca gccggagaac aactacaaga ccacgcctcc cgtgctggac     1260

tccgacggct ccttcttcct cgtcagcaag ctcaccgtgg acaagtctag atggcagcag     1320

gggaacgtct tctcatgctc cgtgatgcat gaggctctgc acaacaggtt cacgcagaag     1380

agcctctccc tgtctccggg taaatgatag                                      1410


<210>  13
<211>  726
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Anti-CD39 LC

<400>  13
gccgccacca tggcctgggt gtggaccctg ctgttcctga tggccgccgc ccagagcatc       60

caggccgata ttgtgttgac ccagtctcct gcctctctgg ctgtgtctct gggacagaga      120

gccaccatct cttgcagagc ctccgagtct gtggacaact tcggcgtgtc cttcatgtac      180

tggttccagc agaagcccgg ccagcctcct aatctgctga tctacggcgc ctccaatcaa      240

ggctctggcg tgccagctag attcagaggc tctggatctg gcaccgactt ctccctgaac      300

atccatccta tggaagccga cgacaccgcc atgtactttt gccagcagac caaagaggtg      360

ccctacacct ttggcggagg caccaagctg gaaatcaaga gaaccgtggc cgctccttcc      420

gtgttcatct tcccaccatc tgacgagcag ctgaagtccg gcacagcttc tgtcgtgtgc      480

ctgctgaaca acttctaccc tcgggaagcc aaggtgcagt ggaaggtgga caatgccctg      540

cagtccggca actcccaaga gtctgtgacc gagcaggact ccaaggactc tacctacagc      600

ctgtcctcca cactgaccct gtctaaggcc gactacgaga agcacaaggt gtacgcctgt      660

gaagtgaccc accagggact gtctagcccc gtgaccaagt ctttcaacag aggcgagtgc      720

tgatga                                                                 726


<210>  14
<211>  1500
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Anti-RSV (clone B21M)

<400>  14
gccgccacca tggcctgggt gtggaccctg ctgttcctga tggccgccgc ccagagcatc       60

caggccgata ttcagatgac ccagtctcct tccagcctgt ctgcctctgt gggcgacaga      120

gtgaccatca cctgtcgggc ctctcagtcc atctcctcct acctgaactg gtatcagcag      180

aagcctggct gcgcccctaa gctgctgatc tatgctgcta gctctctgca gtccggcgtg      240

ccctctagat tttctggctc tggatctggc accgacttca ccctgaccat cagttctctg      300

cagcctgagg acttcgccac ctactactgc cagcagtcct acagcacccc tctgaccttt      360

ggccagggca ccaaggtgga aatcaaaggc ggaggtagcg gcggatctgg cggatgtcct      420

ccttgcggag gttctggcgg agaagtgcag ttgttggaaa gtggcggagg actggttcag      480

cctggcggat ctctgagact gtcttgtgcc gcctccggct tcaccttctc ctcttacgct      540

atgtcctggg tccgacaggc tcctggcaaa ggattggagt gggtgtccgc tatctctgga      600

tccggcggct ctacctacta cgccgattct gtgaagggca gattcaccat cagccgggac      660

aactccaaga acaccctgta cctgcagatg aactccctga gagccgagga caccgccgtg      720

tactactgtg ctaagtacga cggcatctac ggcgagctgg atttttgggg ctgtggcaca      780

ctggtcaccg tgtcctctga gcccaaatct tgtgacaaaa ctcacacatg tccaccgtgc      840

ccagcacctg aactcctggg gggaccgtca gtcttcctct tccccccaaa acccaaggac      900

accctcatga tctcccggac ccctgaggtc acatgcgtgg tggtggacgt gagccacgaa      960

gaccctgagg tcaagttcaa ctggtacgtg gacggcgtgg aggtgcataa tgccaagaca     1020

aagccgcggg aggagcagta caacagcacg taccgtgtgg tcagcgtcct caccgtcctg     1080

caccaggact ggctgaatgg caaggagtac aagtgcaagg tctccaacaa agccctccca     1140

gcccccatcg agaaaaccat ctccaaagcc aaagggcagc cccgagaacc acaggtgtac     1200

accctgcccc catcccggga ggagatgacc aagaaccagg tcagcctgtg gtgcctggtc     1260

aaaggcttct atcccagcga catcgccgtg gagtgggaga gcaatgggca gccggagaac     1320

aactacaaga ccacgcctcc cgtgctggac tccgacggct ccttcttcct ctacagcaag     1380

ctcaccgtgg acaagtctag atggcagcag gggaacgtct tctcatgctc cgtgatgcat     1440

gaggctctgc acaaccacta cacgcagaag agcctctccc tgtctccggg taaatgatag     1500


